Follow LF0 researchXLinkedInSubstackFacebookTelegram
tput: No value for $TERM and no -T specified

Research

Lantheus (LNTH) Stock Analysis & Research

Latest rating
Hold
Latest report
Aug 18, 2026
Reports
1
Sector
Healthcare

Lantheus (LNTH) develops and commercializes radiopharmaceutical diagnostics and related products, with PYLARIFY as its core commercial engine alongside precision diagnostics and newer pipeline assets. Revenue comes from imaging agents, strategic partnerships, and other product sales.

Backtesting dashboard with equity curve and drawdown analysis
Quantitative market report dashboard with factor and risk analysis
SEC filing comparison with highlighted document changes